Skip to main content
ACG 2024 Annual Meeting Main banner
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Award Winner
ACG Newsworthy Abstract
ACG Newsworthy Abstract
Registration Required
Registration Required
No CME
No CME
On-Demand Video
On-Demand Video
Livestream
Livestream
Back

Nadim Mahmud, MD, MS, MPH, MSCE (he/him/his)

Assistant Professor
Hospital of the University of Pennsylvania
Philadelphia, PA

Nadim Mahmud, MD, MS, MPH, MSCE, is a transplant hepatologist and clinical epidemiologist whose research focuses on developing risk prediction tools to improve clinical decision-making for patients with chronic liver disease. He is currently the principle investigator for an ACG Junior Faculty Development Grant, and a recipient of an NIH K08 Career Development Award to identify lapses in projecting surgical mortality risk for patients with end-stage liver disease.This work resulted in the VOCAL-Penn cirrhosis surgical risk score, which is now internationally used as a pre-operative risk stratification tool for patients with cirrhosis being considered for a diverse range of surgical procedures. Dr. Mahmud has previously published widely on acute on chronic liver failure (ACLF), an extremely high-mortality condition impacting patients with cirrhosis. He has developed risk prediction tools for both the development of ACLF, as well as for ACLF short-term mortality. His research also addresses questions pertaining to national liver transplantation outcomes.

Presentation(s):